VALENSCION Trademark

Trademark Overview


On Tuesday, February 13, 2018, a trademark application was filed for VALENSCION with the United States Patent and Trademark Office. The USPTO has given the VALENSCION trademark a serial number of 87796333. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2019. This trademark is owned by Nautilus Holdco, Inc.. The VALENSCION trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for use in the treatment of viral infection, bacterial infection, asthma, allergies, cancer, transplant rejection, inflammatory diseases and disorders, immune diseases and disorders, hereditary diseases and disorders, and auto immune diseases and disorders; pharmaceuticals for use in the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for use in the treatment of hereditary angioedema; pharmaceuticals for use in the treatment of T-cell and B-cell leukemias and lymphomas; medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immun...
valenscion

General Information


Serial Number87796333
Word MarkVALENSCION
Filing DateTuesday, February 13, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 3, 2018

Trademark Statements


Goods and Servicespharmaceuticals for use in the treatment of viral infection, bacterial infection, asthma, allergies, cancer, transplant rejection, inflammatory diseases and disorders, immune diseases and disorders, hereditary diseases and disorders, and auto immune diseases and disorders; pharmaceuticals for use in the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for use in the treatment of hereditary angioedema; pharmaceuticals for use in the treatment of T-cell and B-cell leukemias and lymphomas; medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; medical therapeutic preparations, namely, small molecule chemicals aimed at inhibiting cellular proteins

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNautilus Holdco, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19808

Party NameNautilus Holdco, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19808

Trademark Events


Event DateEvent Description
Monday, April 1, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 1, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 13, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 29, 2018ASSIGNED TO EXAMINER
Thursday, February 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 16, 2018NEW APPLICATION ENTERED IN TRAM